Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

General Mills recalls flour over possible link to E. coli outbreak

General Mills Inc issued a voluntary recall of about 10 million pounds of flour, saying it was working with health officials to investigate an outbreak of E. coli that had sickened 38 people in 20 U.S. states.

Read More »

U.S. FDA Approves Once-daily Jentadueto XR (linagliptin and metformin hydrochloride extended-release) Tablets for Adults with Type 2 Diabetes

The U.S. Food and Drug Administration has approved Jentadueto XR (linagliptin and metformin hydrochloride extended-release) tablets for the treatment of type 2 diabetes (T2D) in adults.

Read More »

U.S. Supreme Court rejects patent appeal over Cubicin drug

The U.S. Supreme Court rejected Cubist Pharmaceuticals Inc’s bid to revive four patents for its antibiotic drug Cubicin, paving the way for rival Hospira Inc to introduce a generic version as soon as this year.

Read More »

Daiichi Sankyo to not proceed with lung cancer study

Daiichi Sankyo Co Ltd said it will not proceed with the second part of its late-stage study on the lung cancer drug, patritumab.

Read More »

Amicus’ Fabry disease drug gets European Commission approval

Amicus Therapeutics Inc said the European Commission approved the use of migalastat, its experimental treatment for Fabry disease, an inherited disease that creates pain and burning in the hands and feet.

Read More »

FDA asks Teva Pharmaceutical for further study on Huntington drug

Israel-based Teva Pharmaceutical Industries said on Tuesday approval for a drug to treat chorea stemming from Huntington disease has been held up by U.S. regulators seeking further blood study.

Read More »

Intercept Pharma’s Liver Drug Wins Accelerated Approval by the FDA

FDA granted accelerated approval to Ocaliva, the first new medicine for primary biliary cholangitis in nearly 20 years.

Read More »

FDA Approves Once-Monthly MS Drug Zinbryta

A once-per-month injection for MS developed by Biogen and AbbVie received FDA approval.

Read More »

Jazz Pharma Pays $1.5 Billion for Celator Pharma

Jazz Pharmaceuticals struck a deal to acquire Celator Pharmaceuticals and its promising leukemia drug for $1.5 billion.

Read More »

Roche’s MabTherea shot gets EU OK for chronic lymphocytic leukemia

Drugmaker Roche has received European approval for an injectable form of antibody therapy MabThera for people with chronic lymphocytic leukemia.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2018 Focus: Top 50 Pharma, Company of the Year and more!


Ad Right Bottom